A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

NCT01486368 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

NETWORK

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: PF-03446962

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]